Commonwealth Equity Services’s Protalix BioTherapeutics PLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $381K | Sell |
|
|||||
|
2025
Q2 | $291K | Buy |
|
|||||
|
2025
Q1 | $128K | Buy |
|
|||||
|
2024
Q4 | $94K | Hold |
|
|||||
|
2024
Q3 | $51K | Sell |
|
|||||
|
2024
Q2 | $59K | Hold |
|
|||||
|
2024
Q1 | $63K | Hold |
|
|||||
|
2023
Q4 | $89K | Hold |
|
|||||
|
2023
Q3 | $83K | Sell |
|
|||||
|
2023
Q2 | $100K | Buy |
|
|||||
|
2023
Q1 | $105 | Hold |
|
|||||
|
2022
Q4 | $68K | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $33K | Buy |
|
|||||
|
2017
Q2 | – | Sell |
|
|||||
|
2017
Q1 | $51K | Buy |
|